Investigator

Prima Dewi Sinawang

Assay Development Scientist · Biosensorix Pte. Ltd.

PDSPrima Dewi Sinawa…
Papers(1)
<scp>PpIX</scp>‐enabl…
Collaborators(4)
Bin ChenBrittany P. RickardImran RizviMarta Overchuk
Institutions(3)
Stanford UniversitySaint Joseph's Univer…University Of North C…

Papers

PpIX‐enabled fluorescence‐based detection and photodynamic priming of platinum‐resistant ovarian cancer cells under fluid shear stress

AbstractOver 75% percent of ovarian cancer patients are diagnosed with advanced‐stage disease characterized by unresectable intraperitoneal dissemination and the presence of ascites, or excessive fluid build‐up within the abdomen. Conventional treatments include cytoreductive surgery followed by multi‐line platinum and taxane chemotherapy regimens. Despite an initial response to treatment, over 75% of patients with advanced‐stage ovarian cancer will relapse and succumb to platinum‐resistant disease. Recent evidence suggests that fluid shear stress (FSS), which results from the movement of fluid such as ascites, induces epithelial‐to‐mesenchymal transition and confers resistance to carboplatin in ovarian cancer cells. This study demonstrates, for the first time, that FSS‐induced platinum resistance correlates with increased cellular protoporphyrin IX (PpIX), the penultimate downstream product of heme biosynthesis, the production of which can be enhanced using the clinically approved pro‐drug aminolevulinic acid (ALA). These data suggest that, with further investigation, PpIX could serve as a fluorescence‐based biomarker of FSS‐induced platinum resistance. Additionally, this study investigates the efficacy of PpIX‐enabled photodynamic therapy (PDT) and the secretion of extracellular vesicles under static and FSS conditions in Caov‐3 and NIH:OVCAR‐3 cells, two representative cell lines for high‐grade serous ovarian carcinoma (HGSOC), the most lethal form of the disease. FSS induces resistance to ALA‐PpIX‐mediated PDT, along with a significant increase in the number of EVs. Finally, the ability of PpIX‐mediated photodynamic priming (PDP) to enhance carboplatin efficacy under FSS conditions is quantified. These preliminary findings in monolayer cultures necessitate additional studies to determine the feasibility of PpIX as a fluorescence‐based indicator, and mediator of PDP, to target chemoresistance in the context of FSS.

20Works
1Papers
4Collaborators
Ovarian NeoplasmsCell Line, TumorBiomarkers, TumorDNA, NeoplasmHIV Infections

Positions

2017–

Assay Development Scientist

Biosensorix Pte. Ltd.

2014–

Project Officer

Nanyang Technological University · Materials Science and Engineering

2011–

Research Intern

Imperial College London · Bioengineering

2010–

NTU President Undergraduate Research Scholar

Nanyang Technological University · Chemical and Biomolecular Engineering

Education

B.Eng (Hons.)

Nanyang Technological University · Chemical and Biomolecular Engineering

2018

MS / PhD Candidate

Stanford University · Bioengineering and Chemical Engineering

Country

US